Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169063 | SCV000220227 | likely pathogenic | Wilson disease | 2014-04-09 | criteria provided, single submitter | literature only | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000169063 | SCV000694425 | likely pathogenic | Wilson disease | 2021-02-28 | criteria provided, single submitter | clinical testing | Variant summary: ATP7B c.2575+1G>C is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes the canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8e-06 in 249552 control chromosomes. c.2575+1G>C has been reported in the literature in individuals affected with Wilson Disease and subsequently cited by others (example, Thomas_1995, Coffey_2013, Singh_2019). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
Gene |
RCV001582664 | SCV001813009 | pathogenic | not provided | 2020-06-04 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 7626145, 23518715) |
Invitae | RCV000169063 | SCV002301498 | likely pathogenic | Wilson disease | 2022-01-19 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 188749). This variant is also known as c.2576+1G>C. Disruption of this splice site has been observed in individual(s) with Wilson disease (PMID: 7626145, 11690702, 23518715). This variant is present in population databases (rs766149114, gnomAD 0.002%). This sequence change affects a donor splice site in intron 10 of the ATP7B gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ATP7B are known to be pathogenic (PMID: 10441329, 16283883). |
Baylor Genetics | RCV000169063 | SCV004216351 | pathogenic | Wilson disease | 2023-08-25 | criteria provided, single submitter | clinical testing |